###begin article-title 0
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
Genetic Analysis of 10 Unrelated Korean Families with p22-phox-deficient Chronic Granulomatous Disease: An Unusually Identical Mutation of the CYBA Gene on Jeju Island, Korea
###end article-title 0
###begin p 1
###xml 635 639 635 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 482 490 <span type="species:ncbi:9606">patients</span>
###xml 537 545 <span type="species:ncbi:9606">patients</span>
Chronic granulomatous disease (CGD) is a rare hereditary disorder characterized by recurrent life-threatening bacterial and fungal infections. The underlying defect in CGD is an inability of phagocytes to produce reactive oxygen species as a result of defects in NADPH oxidase. Considering that CGD generally affects about 3-4 in 1,000,000 individuals, it is surprising that the prevalence of CGD on Jeju Island is 20.7 in 1,000,000 individuals. We performed genetic analysis on 12 patients from 10 unrelated families and found that all patients had an identical homozygous single-base substitution of C to T in exon 1 (c.7C>T) of the CYBA gene, which was expected to result in a nonsense mutation (p.Q3X). Because Jeju Island has long been a geologically isolated region, the high prevalence of CGD on Jeju Island is presumably associated with an identical mutation inherited from a common ancestor or proband.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 632 633 632 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 635 636 635 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 825 826 825 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
Chronic granulomatous disease (CGD) is a rare hereditary disorder characterized by recurrent life-threatening bacterial and fungal infections (1). The underlying defect in CGD is an inability of phagocytes to produce reactive oxygen species (ROS) as a result of defects in NADPH oxidase (2). NADPH oxidase is composed of several structural and regulatory proteins. Two of these, gp91-phox and p22-phox, are integral membrane proteins that form flavocytochromeb558, the electron-transport center of the oxidase. The cytosolic proteins, p40-phox, p47-phox, and p67-phox, exist as a tight complex in the cytosol of resting phagocytes (3, 4). After ingestion of microbes into phagosomes, the cytosolic proteins translocate to the membrane to complex with the flavocytochrome to form activated NADPH oxidase, which generates ROS (5).
###end p 3
###begin p 4
###xml 222 226 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBB</italic>
###xml 336 340 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 362 366 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NCF1</italic>
###xml 392 396 392 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NCF2</italic>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 635 636 635 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 145 153 <span type="species:ncbi:9606">patients</span>
###xml 490 498 <span type="species:ncbi:9606">patients</span>
###xml 581 589 <span type="species:ncbi:9606">patients</span>
CGD is a genetically heterogeneous disease caused by defects in the genes encoding any of the NADPH oxidase components. Approximately 60% of CGD patients showed an X-linked inheritance, which is caused by mutations in the CYBB gene encoding gp91-phox. Autosomal recessive forms of CGD are caused by mutations in one of three genes: the CYBA (p22-phox) gene, the NCF1 (p47-phox) gene, and the NCF2 (p67-phox) gene. Mutations in these three genes collectively account for about 30-40% of CGD patients (6). Mutations in the p67-phox and p22-phox genes are less common, and to date no patients have been reported with defects in p40-phox (6).
###end p 4
###begin p 5
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 702 710 <span type="species:ncbi:9606">patients</span>
Although the prevalence of CGD may actually be higher than reported because of the under-diagnosis of milder phenotypes, the estimated prevalence of CGD is between 1 in 200,000 and 1 in 250,000 individuals, with variable occurrence in different countries (6-11). According to a collation by the Korean College of Pediatric Clinical Immunology, the prevalence of CGD from 2001 to 2005 in Korea was 0.9 in 1,000,000 individuals. Most regions of Korea had similar prevalence of CGD (from 0.4 to 1.7). The prevalence of CGD on Jeju Island was a surprising 20.7, showing 10-50 times higher than that in other regions of Korea (paper in preparation). The aim of this study was to examine the genotype of CGD patients on Jeju Island.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 7
###begin p 8
###xml 67 75 <span type="species:ncbi:9606">patients</span>
###xml 460 468 <span type="species:ncbi:9606">patients</span>
Between January 1993 and December 2007, the available data for CGD patients on Jeju Island were obtained from the medical records of Jeju National University Hospital. The diagnosis of CGD was based on a history of recurrent infections and previously affected family members. The diagnosis was confirmed by an impaired phorbol myristate acetate (PMA)-stimulated nitroblue tetrazolium (NBT) test and/or dihydrorhodamine-1,2,3 (DHR) flow cytometry assay. Twelve patients with CGD (3 males and 9 females) from 10 unrelated families were enrolled for Western blot and mutation analysis. All available family members were analyzed for confirming the heterozygous status.
###end p 8
###begin p 9
###xml 170 178 <span type="species:ncbi:9606">patients</span>
This study was approved by the Institutional Review Board of Jeju National University Hospital (2006-14), and informed consent for genetic analysis was obtained from all patients and/or their parents.
###end p 9
###begin title 10
DHR flow cytometry
###end title 10
###begin p 11
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 354 360 <span type="species:ncbi:9913">bovine</span>
DHR flow cytometry was used to evaluate the generation of ROS by phagocytic cells as previously described (12). Red blood cells were lysed by mixing 400 microL of whole blood with 4 mL of lysis buffer (174 mM ammonium chloride, 20 mM sodium bicarbonate, and 1 mM EDTA). White blood cells (WBCs) suspended in Hank's buffered salt solution containing 0.1% bovine serum albumin were loaded with 1 mM EDTA, followed by 1 unit/microL catalase (Roche Diagnostic Cooperation, Indianapolis, IN, U.S.A.) and 100 mM DHR (Molecular Probes, Eugene, OR, U.S.A.). PMA (Sigma-Aldrich, St. Louis, MO, U.S.A.) was added to the cells at a final concentration of 20 ng/mL, and the cells were incubated for 15 min. After incubation, the cells that had formed rhodamine by oxidizing DHR were counted with an EPICS(R) XL flow cytometer (Coulter, Miami, FL, U.S.A.).
###end p 11
###begin title 12
Western blot analysis of the NADPH oxidase components
###end title 12
###begin p 13
###xml 813 819 <span type="species:ncbi:9986">rabbit</span>
###xml 828 833 <span type="species:ncbi:10090">mouse</span>
WBCs were solubilized in a lysis buffer containing 100 mM KCl, 10 mM NaCl, 10 mM HEPES, 1 mM EDTA (pH 7.4), 0.1 mM DTT, 1 mM PMSF, 10 microg/mL chymostatin, 1 microg/mL protease inhibitor cocktail (Sigma-Aldrich), 1% Triton X-100, 1% deoxycholic acid, 1% NP-40, and 0.05% SDS. The protein content of the cell lysate was resolved by 5-20% SDS-PAGE and electroblotted onto nitrocellulose membranes. Following a blocking step, the membranes were incubated for 2 hr with the following primary antibodies diluted 1:1,000: polyclonal anti-p22-phox (FL-195), anti-p47-phox (H-195), anti-p67-phox (H-300), and anti-p40-phox (D-8) (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.); and anti-gp91-phox (Upstate, Lake Placid, NY, U.S.A.). After multiple washing steps, the membranes were incubated with HRP-conjugated anti-rabbit or anti-mouse IgG (1:10,000 dilution; Vector, Burlingame, CA, U.S.A.). Immunoblot signals were visualized with an Enhanced Chemiluminescence Detection System (Pierce Biotechnology, Rockford, IL, U.S.A.).
###end p 13
###begin title 14
Isolation of total RNA and RT-RCR
###end title 14
###begin p 15
###xml 522 526 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 649 652 627 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
Total RNA was extracted from WBCs using an RNeasy(R) mini kit (QIAGEN, Valencia, CA, U.S.A.), following the manufacturer's instructions. First-strand cDNA was synthesized from 2 microg of RNA with 25 ng/mL Oligo dT (Promega, Madison, WI, U.S.A.), 0.5 mM dNTP mix, 0.2 unit/microL Omniscript (QIAGEN), and 0.5 unit/microL RNase inhibitor. The reaction was incubated at 37℃ for 60 min. The synthesized cDNA was amplified using primers (Forward, 5'-ATG GGG CAG ATC GAG TGG GC-3'and Reverse, 5'-TCA CAC GAC CTC GTC GGT CA-3'; CYBA accession number, NM_000101) in a 50-microL PCR reaction containing 0.2 mM dNTP mix, 0.4 microM primer, and 1.25 units of Taq polymerase (Promega). The PCR conditions were 35 cycles of denaturation at 94℃ for 15 sec, annealing at 62℃ for 30 sec, and extension at 72℃ for 1 min. The RT-PCR products were separated in a 2% agarose gel and stained with ethidium bromide for visualization.
###end p 15
###begin title 16
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
Isolation and amplification of genomic DNA of CYBA
###end title 16
###begin p 17
###xml 245 247 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 668 669 662 663 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 688 691 682 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
Genomic DNA was extracted from peripheral blood using a Wizard(R) genomic DNA purification kit (Promega) according to the manufacture's protocol. The six exons of CYBA and the exon-intron junctions were amplified by PCR as previously described (13). Primers used for 5'and 3'untranslated region are as follow; 5'untranslated region: forward 5'-AAA CCA CCA AGT GCC TCG GAT G-3'and reverse 5'-TGA GCC AAT GTG GGG TTT GAG G-3', 3'untranslated region: forward 5'-CAG GCC GAC CCA GGT CCT GGC-3'and reverse 5'-CGG CCC CAG GCA GAG GCT CA-3'. PCR was performed in a 50-microL reaction mixture containing 10 pM of each primer, 0.2 mM dNTPs, 100 mM Tris-HCl, pH 8.3, 1.5 mM MgCl2, and 2.0 units of Taq polymerase (Promega). The amplification conditions were 35 cycles of 95℃ for 1 min, 59℃ for 1 min, and 72℃ for 1 min; followed by a final extension time of 5 min at 72℃. The PCR products were separated in a 1.5% agarose gel and stained with ethidium bromide for visualization.
###end p 17
###begin title 18
Sequence analysis
###end title 18
###begin p 19
###xml 485 492 485 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GenBank</italic>
###xml 422 430 <span type="species:ncbi:9606">patients</span>
PCR-amplified products were purified using a QIAquick PCR purification kit (QIAGEN, Hilden, Germany) and analyzed by direct sequencing in both directions using an ABI-Prism BigDye Terminator Cycle Sequencing Ready Reaction kit and an ABI Prism 3130 XL Genetic Analyzer (Applied Biosystems, Foster City, CA, U.S.A.). Primers for the sequencing reactions were the same as those used for PCR. The sequences obtained from CGD patients and healthy controls were compared with GenBank data (GenBank accession number, NM_000101) and submitted for BLAST analysis.
###end p 19
###begin title 20
RESULTS
###end title 20
###begin p 21
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 291 299 <span type="species:ncbi:9606">patients</span>
Between 1993 and 2007, 17 patients from 11 unrelated families on Jeju Island were identified as having CGD. There were 7 males and 10 females, and 5 families (45%) had multiple affected siblings. The diagnosis of CGD was made at a mean age of 2.1 yr (median, 0.5 yr; range 0.1-5.4 yr). Four patients (24%) died during the period, at a mean age of 4.7 yr (range, 0.9 to 14.3 yr). Judging from this study, the prevalence of CGD on Jeju Island is 23.1 in 1,000,000 individuals (Statistics from Jeju Special Self-Governing Province, 2007).
###end p 21
###begin p 22
###xml 123 130 123 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 422 428 422 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 613 619 613 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 27 35 <span type="species:ncbi:9606">patients</span>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
###xml 265 273 <span type="species:ncbi:9606">patients</span>
###xml 508 516 <span type="species:ncbi:9606">patients</span>
###xml 603 611 <span type="species:ncbi:9606">patients</span>
###xml 636 644 <span type="species:ncbi:9606">patients</span>
Among the CGD patients, 12 patients from 10 families were analyzed by DHR flow cytometric assay and Western blot analysis (Table 1). The ages of the patients at the time of genetic analysis ranged from 3.3 to 28.2 yr. With the DHR flow cytometric assay, all of the patients showed an absence of ROS production, but all other family members with normal phenotype did not show any impairment compared with healthy controls (Fig. 1). Western blot analysis demonstrated the absence of p22-phox expression in all patients, while the expression of gp91-phox, p47-phox, p67phox, and p40-phox was normal in all patients (Fig. 2). Thus, all the patients exhibited the A22degrees biochemical phenotype of the disease.
###end p 22
###begin p 23
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 177 183 177 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 223 227 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 586 590 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 597 603 597 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 251 259 <span type="species:ncbi:9606">patients</span>
###xml 469 477 <span type="species:ncbi:9606">patients</span>
###xml 682 690 <span type="species:ncbi:9606">patients</span>
The mRNA of CYBA gene was reverse transcribed as described above. The cDNA for p22-phox in all patients and family members did not differ in size from that in healthy controls (Fig. 3). Sequence analysis of genomic DNA for CYBA gene revealed that all patients had an identical, homozygous, single-base substitution of C to T in exon 1 (c.7C>T), which was expected to result in a nonsense mutation (p.Q3X). The genomic DNA sequencing results for both parents of all the patients showed a double signal at the same position, which indicated they were heterozygous for the mutation in the CYBA gene (Fig. 4). This mutation has been previously reported at the same position in Japanese patients (14, 15).
###end p 23
###begin p 24
###xml 108 112 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 206 213 206 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
In addition to the mutation described above, six different single nucleotide substitutions (SNP) within the CYBA gene were detected in all patients in the same manner during the course of genetic analysis (Table 2).
###end p 24
###begin title 25
DISCUSSION
###end title 25
###begin p 26
###xml 313 321 <span type="species:ncbi:9606">patients</span>
###xml 398 406 <span type="species:ncbi:9606">patients</span>
###xml 574 582 <span type="species:ncbi:9606">patients</span>
Jeju is a large island off southwest of Korean peninsula. The total population of Jeju Island is 563,388 (Statistics of Jeju Special Self-Governing Province, 2007). Mt. Halla rises in the center of Jeju Island, dividing it into two geographically separated regions, Jeju City and Seogwipo City. In this study, 17 patients from 11 unrelated families on Jeju Island were identified as having CGD; 14 patients were from Seogwipo City and three from Jeju City. The overall prevalence of CGD on Jeju Island is 23.1 in 1,000,000 individuals. Although we tried to identify as many patients as possible, this may be an underestimation of the actual prevalence of CGD on Jeju Island.
###end p 26
###begin p 27
###xml 382 386 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 433 434 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 766 770 766 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 810 814 810 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 1005 1007 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1228 1230 1228 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1232 1234 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 423 431 <span type="species:ncbi:9606">patients</span>
###xml 497 502 <span type="species:ncbi:9606">Human</span>
###xml 697 705 <span type="species:ncbi:9606">patients</span>
###xml 879 887 <span type="species:ncbi:9606">patients</span>
###xml 952 960 <span type="species:ncbi:9606">patients</span>
We hypothesized that the high prevalence of CGD on Jeju Island is associated with an identical mutation inherited from a common ancestor or proband. According to the studies carried out to date, the most common form of CGD is the X-linked form. The approximately 30-40% of CGD are inherited in an autosomal recessive traits. One of the rarest forms of CGD is caused by mutations in CYBA gene, accounting for only 5% of CGD patients (6). Up to the date, 27 mutations in CYBA gene are listed in the Human Gene Mutation Database (HGMD; ) and all 27 mutations reported for CYBA gene showed the allelic heterogeneity with no preponderance of common affected alleles or hot spots (16). However, all CGD patients on Jeju Island had an identical, homozygous mutation in the CYBA gene and six different SNPs within the CYBA gene in the same manner. Moreover, one of the reported Japanese patients with p22-phox-deficient CGD, sharing the same mutation with CGD patients on Jeju Island, has consanguineous parents (14). In regions with a higher incidence of consanguinity in the population, there is an increase in the prevalence of autosomal recessive genetic disorders, including CGD, as a direct result of a higher rate of inbreeding (10, 11). Altogether, these results strongly suggest that there might have been unique marriage patterns similar to endogamy or consanguineous marriage on Jeju Island.
###end p 27
###begin p 28
###xml 33 35 33 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 36 38 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
In contrast to previous reports (13-16), a normal level of gp91-phox protein expression was detected in all CGD patients on Jeju Island. By using transgenic expression of gp91-phox and p22-phox in monkey kidney COS7 cells, which lack endogenous p22-phox and gp91-phox expression, gp91-phox was expressed on the cell surface in the absence of p22-phox expression. However, co-expression of gp91-phox and p22-phox were required to support the generation of oxygen radicals in a cell-free NADPH oxidase assay (17). This implies that the association of p22-phox with gp91-phox may be essential for regulation of electron transfer in the redox cycle, but p22-phox may not be necessary for the expression of gp91-phox protein. Further studies are required to understand the expression of gp91-phox in p22-phox-deficient CGD.
###end p 28
###begin p 29
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 689 697 <span type="species:ncbi:9606">patients</span>
###xml 792 800 <span type="species:ncbi:9606">patients</span>
###xml 870 878 <span type="species:ncbi:9606">patients</span>
Based on different clinical parameters, X-linked CGD has a different, more severe, clinical phenotype than the autosomal recessive CGD (6). The prognosis of X-linked CGD and p22-phox-deficient CGD was not better than that of p47-phox-deficient CGD (10), and p22-phox-deficient CGD with the young age at diagnosis appears to be as severe as X-linked CGD (16). Although genetic study has not been performed, X-linked CGD had a significantly earlier age of symptom onset and age at diagnosis than autosomal recessive CGD in Korea (18). To our knowledge, there were only 2 reports about the genetic analysis of X-linked CGD in Korea (19, 20). It is hard to evaluate the clinical course of CGD patients on Jeju Island in comparison with the different genotype. However, the clinical course of CGD patients on Jeju Island seems to be considered mild in that 30% of the living patients are 20 yr of age or older.
###end p 29
###begin p 30
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 1028 1032 1028 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
###xml 737 743 <span type="species:ncbi:9606">people</span>
There is an increase in the prevalence of autosomal recessive genetic disorders in regions with a higher incidence of consanguinity in the population, as a result of a higher rate of inbreeding. All the CGD patients tested on Jeju Island had an identical and homozygous mutation in the CYBA gene. This result is specific to our cohort, as the most common form of CGD in other reports is the X-linked form of CGD. Even though this study is not a nationwide survey of CGD in Korea, the finding of an identical mutation in a single region with a highly prevalent rate is quite unique. This is not consistent with the generally accepted principle of recessively inherited rare diseases. In Korea, there is a law prohibiting marriage between people with the same surname and the same family origin. However, since Jeju Island has been a geologically isolated region for a long time, there might have been unique marriage patterns similar to endogamy or consanguineous marriage. This may explain the unusual identical mutation of the CYBA gene and the high prevalence of autosomal recessive forms of CGD on Jeju Island. We are preparing to investigate the genotyping further by using microsatellite markers. This approach may help to elucidate the genetic characteristics of the population by revealing a particular familial structure on Jeju Island.
###end p 30
###begin p 31
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 458 462 458 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
In this study, six SNPs within the CYBA gene were detected in the course of genetic analysis. Although we did not check for these SNP sites in a larger scale population, two SNPs in the CYBA gene have not yet been registered as a polymorphism in the database of SNPs (): one located at nucleotide position G-36>A, which changes 13 Q codon GGG into the alternative Q codon GGA; and the other at nucleotide position 646 C>T in the 3'untranslated region of the CYBA gene.
###end p 31
###begin p 32
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
In conclusion, we demonstrate all patients of CGD in Jeju Island have an identical, homozygous mutation in the CYBA gene.
###end p 32
###begin title 33
ACKNOWLEDGMENTS
###end title 33
###begin p 34
###xml 28 36 <span type="species:ncbi:9606">patients</span>
We gratefully thank all the patients and their families for their devoted cooperation in this study.
###end p 34
###begin p 35
###xml 54 87 54 87 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jeju National University Hospital</funding-source>
This work was partially supported by a grant from the Jeju National University Hospital Research Fund (2006).
###end p 35
###begin article-title 36
Chronic granulomatous disease
###end article-title 36
###begin article-title 37
Genetic, biochemical and clinical features of chronic granulomatous disease
###end article-title 37
###begin article-title 38
Architecture of the p40-p47-p67phox complex in the resting state of the NADPH oxidase, a central role for p67phox
###end article-title 38
###begin article-title 39
Chronic granulomatous disease
###end article-title 39
###begin article-title 40
Regulation of the NADPH-oxidase complex of phagocytic leukocytes. Recent insights from structural biology, molecular genetics, and microscopy
###end article-title 40
###begin article-title 41
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Chronic granulomatous disease: report on a national registry of 368 patients
###end article-title 41
###begin article-title 42
Chronic granulomatous disease in Japan: incidence and natural history. The study group of Phagocyte Disorders of Japan
###end article-title 42
###begin article-title 43
Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden
###end article-title 43
###begin article-title 44
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study
###end article-title 44
###begin article-title 45
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients
###end article-title 45
###begin article-title 46
Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia
###end article-title 46
###begin article-title 47
Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes
###end article-title 47
###begin article-title 48
Molecular analysis of nine new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22 (phox)
###end article-title 48
###begin article-title 49
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
Genetic studies of three Japanese patients with p22-phox-deficient chronic granulomatous disease: detection of a possible common mutant CYBA allele in Japan and a genotype-phenotype correlation in these patients
###end article-title 49
###begin article-title 50
Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency
###end article-title 50
###begin article-title 51
Characterization of six novel mutations in CYBA: the gene causing autosomal recessive chronic granulomatous disease
###end article-title 51
###begin article-title 52
Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase
###end article-title 52
###begin article-title 53
Clinical study on chronic granulomatous disease in Korea
###end article-title 53
###begin article-title 54
A case of X-linked chronic granulomatous disease diagnosed in identical twin
###end article-title 54
###begin article-title 55
###xml 86 94 <span type="species:ncbi:9606">patients</span>
Molecular analysis of X-linked chronic granulomatous disease in five unrelated Korean patients
###end article-title 55
###begin article-title 56
Cytochrome b558-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b558 light chain of the NADPH oxidase (p22-phox)
###end article-title 56
###begin p 57
###xml 182 189 <span type="species:ncbi:9606">patient</span>
###xml 355 362 <span type="species:ncbi:9606">patient</span>
Dihydrorhodamine-1,2,3 (DHR) flow cytometric analysis of granulocyte oxidative activity in family III. There was no difference in phagocyte oxidative activity between the parents of patient 4 and healthy controls after no stimulation (black) or stimulation with PMA (red). A lack of phagocyte oxidative activity after stimulation with PMA was observed in patient 4.
###end p 57
###begin p 58
###xml 138 146 <span type="species:ncbi:9606">patients</span>
Western blot analysis of NADPH oxidase components in family III. Western blot analysis demonstrated the absence of p22-phox expression in patients 4 and 5, but the expression of gp91phox, p47-phox, p67phox, and p40-phox were normal. There was no abnormal expression of any NADPH oxidase components in other family members.
###end p 58
###begin p 59
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 66 73 <span type="species:ncbi:9606">Patient</span>
###xml 96 103 <span type="species:ncbi:9606">patient</span>
###xml 111 118 <span type="species:ncbi:9606">Patient</span>
###xml 144 151 <span type="species:ncbi:9606">patient</span>
F, Father of patients 4 and 5; M, Mother of patients 4 and 5; P4, Patient 4; S, Elder sister of patient 5; P5, Patient 5; B, Younger brother of patient 5.
###end p 59
###begin p 60
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
RT-PCR of CYBA cDNA from family III. The mRNA of p22-phox was reverse transcribed as described above. There was no difference in size between the p22-phox cDNAs in family III and those in healthy controls.
###end p 60
###begin p 61
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 66 73 <span type="species:ncbi:9606">Patient</span>
###xml 96 103 <span type="species:ncbi:9606">patient</span>
###xml 111 118 <span type="species:ncbi:9606">Patient</span>
###xml 144 151 <span type="species:ncbi:9606">patient</span>
F, Father of patients 4 and 5; M, Mother of patients 4 and 5; P4, Patient 4; S, Elder sister of patient 5; P5, Patient 5; B, Younger brother of patient 5.
###end p 61
###begin p 62
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 53 54 53 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 81 82 81 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 136 144 <span type="species:ncbi:9606">Patients</span>
Sequence analysis of the CYBA gene from family III. (A) Pedigree of family III. (B) Sequence analysis of the CYBA gene from family III. Patients 4 and 5 had an identical, homozygous, single-base substitution of C- to T in exon 1 (c.7C>T), which was expected to result in a nonsense mutation (p.Q3X). The sequencing results for other family members showed a double signal at the same position, indicating that they were heterozygous for the mutation.
###end p 62
###begin p 63
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*site of mutation.
###end p 63
###begin p 64
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 66 73 <span type="species:ncbi:9606">Patient</span>
###xml 96 103 <span type="species:ncbi:9606">patient</span>
###xml 111 118 <span type="species:ncbi:9606">Patient</span>
###xml 144 151 <span type="species:ncbi:9606">patient</span>
F, Father of patients 4 and 5; M, Mother of patients 4 and 5; P4, Patient 4; S, Elder sister of patient 5; P5, Patient 5; B, Younger brother of patient 5.
###end p 64
###begin p 65
###xml 23 31 <span type="species:ncbi:9606">patients</span>
Characteristics of CGD patients in Jeju, Korea
###end p 65
###begin p 66
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 15 21 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
*age at death; daggerconfirmed by NBT test.
###end p 66
###begin p 67
CGD, Chronic granulomatous disease; NBT, Nitroblue tetrazolium; DHR, Dihydrorhodamine-1,2,3; Phox, Phagocyte oxidase; ND, Not determined.
###end p 67
###begin p 68
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYBA</italic>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Single nucleotide substitution within the CYBA gene in CGD patients
###end p 68
###begin p 69
CGD, Chronic granulomatous disease; UT region, Untranslated region; NA, Not applicable; NR, Not registered.
###end p 69

